Open | $11.760 |
Close | $11.420 |
Volume / Avg. | 11.375M / 6.970M |
Day Range | 11.170 - 12.345 |
52 Wk Range | 4.540 - 16.745 |
Market Cap | $2.647B |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 49 |
Short Interest | 24.47% |
Days to Cover | 6.91 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Recursion Pharmaceuticals (NASDAQ: RXRX) through any online brokerage.
Other companies in Recursion Pharmaceuticals’s space includes: IDEAYA Biosciences (NASDAQ:IDYA), MoonLake (NASDAQ:MLTX), TG Therapeutics (NASDAQ:TGTX), PTC Therapeutics (NASDAQ:PTCT) and Dyne Therapeutics (NASDAQ:DYN).
The latest price target for Recursion Pharmaceuticals (NASDAQ: RXRX) was reported by Keybanc on Monday, March 4, 2024. The analyst firm set a price target for 16.00 expecting RXRX to rise to within 12 months (a possible 41.84% upside). 18 analyst firms have reported ratings in the last year.
The stock price for Recursion Pharmaceuticals (NASDAQ: RXRX) is $11.28 last updated March 18, 2024 at 7:59 PM EDT.
There are no upcoming dividends for Recursion Pharmaceuticals.
Recursion Pharmaceuticals’s Q1 earnings are confirmed for Monday, May 6, 2024.
There is no upcoming split for Recursion Pharmaceuticals.
Recursion Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.